EUVIMEDEUVIMED entdecken
Crossref

YBX1 promotes epithelial-mesenchymal transition in hepatocellular carcinoma via transcriptional regulation of PLRG1

Jae Hwan Kwon, Sang Hoon Kim

Medical Oncology · 2024

DOI: 10.1007/s12032-024-02516-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Oncology, 2024. Verfasst von Jae Hwan Kwon und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Kyung Hee University, Seoul, 02447, Republic of Korea. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Cell Movement, Epithelial-Mesenchymal Transition, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC) ranks as the sixth most prevalent cancer worldwide. The epithelial-mesenchymal transition (EMT) is a critical process in cancer progression, contributing to increased malignancy. While Pleiotropic Regulator 1 (PLRG1) is upregulated in HCC and is associated with enhanced cell proliferation, its oncogenic role in EMT remains unclear. In this study, we demonstrate that PLRG1 promotes EMT in HCC cells. Knockdown of PLRG1 in Huh7 cells resulted in decreased expression of the EMT markers N-cadherin and Snail, and impaired cell migration and invasion. Chromatin immunoprecipitation (ChIP) and luciferase assays identified Y-box binding protein 1 (YBX1) as a direct regulator of PLRG1 transcription, binding to its promoter region. Overexpression of YBX1 in SNU-449 cells led to increased PLRG1 expression and subsequent EMT activation, as well as enhanced migration, and invasion. These effects were attenuated by PLRG1 knockdown. Our findings indicate that YBX1 drives EMT in HCC by upregulating PLRG1, offering novel insights into the molecular mechanisms underlying HCC progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularCell MovementEpithelial-Mesenchymal TransitionGene Expression Regulation, NeoplasticLiver NeoplasmsY-Box-Binding Protein 1Nuclear ProteinsIntracellular Signaling Peptides and ProteinsHumansCell Line, TumorCell Proliferation

Stichwörter der Autor:innen

Epithelial-mesenchymal transitionHepatocellular carcinomaInvasionMigrationPLRG1YBX1

Substanzen

Y-Box-Binding Protein 1YBX1 protein, humanPLRG1 protein, humanNuclear ProteinsIntracellular Signaling Peptides and Proteins

Autor:innen und Institutionen

  • Department of Biology, Kyung Hee University, Seoul, 02447, Republic of Korea.
  • Department of Biology, Kyung Hee University, Seoul, 02447, Republic of Korea. shkim@khu.ac.kr.

Förderung

  • National Research Foundation of Korea

Zitieren

APA

Kwon, J. H., & Kim, S. H. (2024). YBX1 promotes epithelial-mesenchymal transition in hepatocellular carcinoma via transcriptional regulation of PLRG1. Medical Oncology. https://doi.org/10.1007/s12032-024-02516-0

Vancouver

Kwon JH, Kim SH. YBX1 promotes epithelial-mesenchymal transition in hepatocellular carcinoma via transcriptional regulation of PLRG1. Medical Oncology. 2024. doi:10.1007/s12032-024-02516-0

BibTeX
@article{Kwon2024,
  author = {Kwon, Jae Hwan and Kim, Sang Hoon},
  title = {YBX1 promotes epithelial-mesenchymal transition in hepatocellular carcinoma via transcriptional regulation of PLRG1},
  journal = {Medical Oncology},
  year = {2024},
  doi = {10.1007/s12032-024-02516-0}
}
Kostenlos starten →